Stock listing
Spermosens Ab
Selected listing: A3CU16 · LS · EUR · DE
Spermosens Ab (Lang & Schwarz: A3CU16), Health Technology. Latest release May 7, 2026: Spermosens secures SEK 4.85 million capital facility to support…
- Ticker
- Lang & Schwarz: A3CU16
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Lang & Schwarz
- Currency
- EUR
About Spermosens Ab
Spermosens Ab (SPERM) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Spermosens Ab
Spermosens secures SEK 4.85 million capital facility to support development and commercialization
May 7, 2026
Spermosens AB (publ) INTERIM REPORT JANUARY - MARCH 2026
May 7, 2026
Spermosens completes development of JUNO-Checked Generation 3 and initiates clinical validation study
April 8, 2026
Spermosens AB (publ)YEAR-END REPORT JANUARY - DECEMBER 2025
February 11, 2026
Spermosens announces outcome of exercise of warrants series TO 4
December 8, 2025
Research Spermosens Ab
Alternate listings
SPERM:NGM
SE · SEK
Alternate listing for Spermosens Ab; the primary context on this page is A3CU16:LS.
A3CU16:LSX
DE · EUR
Alternate listing for Spermosens Ab; the primary context on this page is A3CU16:LS.
9R5:FWB
DE · EUR
Alternate listing for Spermosens Ab; the primary context on this page is A3CU16:LS.
9R5:SWB
DE · EUR
Alternate listing for Spermosens Ab; the primary context on this page is A3CU16:LS.